ARTICLE | Top Story
FDA approves QLT's Aczone
July 8, 2005 12:30 AM UTC
The FDA granted marketing approval to QLT (TSE:QLT; QLTI) for its Aczone dapsone topical gel to treat acne. Yesterday, QLT announced that it acquired North American marketing rights to Aczone, giving ...